Cerebral Vasospasm in Subarachnoid Hemorrhage

Area of Science:

• Neurology
• Neurosurgery
• Critical Care Medicine

Background:

• Vasospasm following subarachnoid hemorrhage (SAH) presents a significant clinical challenge.
• Early detection and management are crucial to prevent secondary ischemic brain injury.
• Current therapeutic strategies aim to optimize cerebral perfusion and mitigate vasospasm effects.

Purpose of the Study:

• To outline current best practices for the recognition and management of vasospasm post-SAH.
• To review the efficacy and limitations of various medical and endovascular treatment modalities.
• To highlight areas where further research is needed, such as the role of hypothermia.

Main Methods:

• Review of established guidelines and literature on SAH and vasospasm management.
• Discussion of diagnostic indicators, including transcranial Doppler (TCD) studies.
• Description of therapeutic interventions: fluid/sodium management, nimodipine, hemodynamic augmentation, angioplasty, and intra-arterial vasodilators.

Main Results:

• Adequate fluid and sodium supplementation are essential; prophylactic hypervolemia is not recommended.
• Oral nimodipine is effective in preventing delayed ischemic damage.
• Transcranial Doppler (TCD) is reliable for early vasospasm detection.
• Hemodynamic augmentation (hypervolemia, hypertension) and endovascular interventions (angioplasty, intra-arterial vasodilators) are effective for symptomatic vasospasm.
• Angioplasty offers durable benefits for focal vasospasm; intra-arterial vasodilators provide temporary relief for diffuse vasospasm.

Conclusions:

• A multi-faceted approach combining medical and interventional therapies is necessary for managing vasospasm after SAH.
• Prompt recognition and aggressive treatment are vital to improve patient outcomes.
• Further investigation into adjunctive therapies like hypothermia is warranted.